Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes

Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates ar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical science (Cambridge) 2021-04, Vol.12 (21), p.7510-7520
Hauptverfasser: Bataglioli, Janaina C., Gomes, Luiza M. F., Maunoir, Camille, Smith, Jason R., Cole, Houston D., McCain, Julia, Sainuddin, Tariq, Cameron, Colin G., McFarland, Sherri A., Storr, Tim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7520
container_issue 21
container_start_page 7510
container_title Chemical science (Cambridge)
container_volume 12
creator Bataglioli, Janaina C.
Gomes, Luiza M. F.
Maunoir, Camille
Smith, Jason R.
Cole, Houston D.
McCain, Julia
Sainuddin, Tariq
Cameron, Colin G.
McFarland, Sherri A.
Storr, Tim
description Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru( ii ) polypyridyl complexes ( Ru1–3 ) alters the aggregation profile of the Aβ peptide. Photoactivation of Ru1–3 results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording cis -exchangeable coordination sites for binding to the Aβ peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5- f ][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for Ru3 , and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1–3 in the presence of pre-formed Aβ 1–42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1–3 in the presence of either monomeric or fibrillar Aβ 1–42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.
doi_str_mv 10.1039/D1SC00004G
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2535830547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</originalsourceid><addsrcrecordid>eNpVkU1Lw0AQhhdRbKm9-AsWvKgQ3c3k8yJI1SpUBD_Oy2Yzm25Js3GTFPPvTWmpOJcZZp5554Uh5JyzG84gvX3gHzM2RDA_ImOfBdyLQkiPD7XPRmTaNKstA8BDPz4lIwh4BEngj4l9tbnRRsnW2IpaTeW6L63JvQxbSWusW5MjlUXhsNgxGzP0l7a1UrVmc9hrWidNhTl97y6pMfSK1rbs696ZvC-psuu6xB9szsiJlmWD032ekK-nx8_Zs7d4m7_M7heeAg6t52vJkjTIYpkjgkxjlgGmLFWQZTGXkc4C9COVJhHnmmOkIZCYgEoilYdhFsGE3O106y5bY66wGvyVonZmLV0vrDTi_6QyS1HYjUh4zMFng8DFXsDZ7w6bVqxs56rBs_BDCBNgYRAP1PWOUs42jUN9uMCZ2P5H_P0HfgFtbINq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2535830547</pqid></control><display><type>article</type><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</creator><creatorcontrib>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</creatorcontrib><description>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru( ii ) polypyridyl complexes ( Ru1–3 ) alters the aggregation profile of the Aβ peptide. Photoactivation of Ru1–3 results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording cis -exchangeable coordination sites for binding to the Aβ peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5- f ][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for Ru3 , and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1–3 in the presence of pre-formed Aβ 1–42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1–3 in the presence of either monomeric or fibrillar Aβ 1–42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</description><identifier>ISSN: 2041-6520</identifier><identifier>EISSN: 2041-6539</identifier><identifier>DOI: 10.1039/D1SC00004G</identifier><identifier>PMID: 34163842</identifier><language>eng</language><publisher>Cambridge: Royal Society of Chemistry</publisher><subject>Agglomeration ; Aggregates ; Alzheimer's disease ; Binding ; Brain damage ; Chemistry ; Ligands ; Morphology ; Peptides ; Ruthenium compounds ; Size distribution ; Toxicity</subject><ispartof>Chemical science (Cambridge), 2021-04, Vol.12 (21), p.7510-7520</ispartof><rights>Copyright Royal Society of Chemistry 2021</rights><rights>This journal is © The Royal Society of Chemistry 2021 The Royal Society of Chemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</citedby><cites>FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</cites><orcidid>0000-0001-7380-2192 ; 0000-0002-3163-6218 ; 0000-0002-8028-5055 ; 0000-0003-3368-2063</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171320/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171320/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Bataglioli, Janaina C.</creatorcontrib><creatorcontrib>Gomes, Luiza M. F.</creatorcontrib><creatorcontrib>Maunoir, Camille</creatorcontrib><creatorcontrib>Smith, Jason R.</creatorcontrib><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>McCain, Julia</creatorcontrib><creatorcontrib>Sainuddin, Tariq</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><creatorcontrib>Storr, Tim</creatorcontrib><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><title>Chemical science (Cambridge)</title><description>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru( ii ) polypyridyl complexes ( Ru1–3 ) alters the aggregation profile of the Aβ peptide. Photoactivation of Ru1–3 results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording cis -exchangeable coordination sites for binding to the Aβ peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5- f ][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for Ru3 , and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1–3 in the presence of pre-formed Aβ 1–42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1–3 in the presence of either monomeric or fibrillar Aβ 1–42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</description><subject>Agglomeration</subject><subject>Aggregates</subject><subject>Alzheimer's disease</subject><subject>Binding</subject><subject>Brain damage</subject><subject>Chemistry</subject><subject>Ligands</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Ruthenium compounds</subject><subject>Size distribution</subject><subject>Toxicity</subject><issn>2041-6520</issn><issn>2041-6539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkU1Lw0AQhhdRbKm9-AsWvKgQ3c3k8yJI1SpUBD_Oy2Yzm25Js3GTFPPvTWmpOJcZZp5554Uh5JyzG84gvX3gHzM2RDA_ImOfBdyLQkiPD7XPRmTaNKstA8BDPz4lIwh4BEngj4l9tbnRRsnW2IpaTeW6L63JvQxbSWusW5MjlUXhsNgxGzP0l7a1UrVmc9hrWidNhTl97y6pMfSK1rbs696ZvC-psuu6xB9szsiJlmWD032ekK-nx8_Zs7d4m7_M7heeAg6t52vJkjTIYpkjgkxjlgGmLFWQZTGXkc4C9COVJhHnmmOkIZCYgEoilYdhFsGE3O106y5bY66wGvyVonZmLV0vrDTi_6QyS1HYjUh4zMFng8DFXsDZ7w6bVqxs56rBs_BDCBNgYRAP1PWOUs42jUN9uMCZ2P5H_P0HfgFtbINq</recordid><startdate>20210424</startdate><enddate>20210424</enddate><creator>Bataglioli, Janaina C.</creator><creator>Gomes, Luiza M. F.</creator><creator>Maunoir, Camille</creator><creator>Smith, Jason R.</creator><creator>Cole, Houston D.</creator><creator>McCain, Julia</creator><creator>Sainuddin, Tariq</creator><creator>Cameron, Colin G.</creator><creator>McFarland, Sherri A.</creator><creator>Storr, Tim</creator><general>Royal Society of Chemistry</general><general>The Royal Society of Chemistry</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7380-2192</orcidid><orcidid>https://orcid.org/0000-0002-3163-6218</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0003-3368-2063</orcidid></search><sort><creationdate>20210424</creationdate><title>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</title><author>Bataglioli, Janaina C. ; Gomes, Luiza M. F. ; Maunoir, Camille ; Smith, Jason R. ; Cole, Houston D. ; McCain, Julia ; Sainuddin, Tariq ; Cameron, Colin G. ; McFarland, Sherri A. ; Storr, Tim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-2fa0894b7adee3a970b3e909c3bb71a6fb4e26c98611f1e6f34ae83c86cd55b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Agglomeration</topic><topic>Aggregates</topic><topic>Alzheimer's disease</topic><topic>Binding</topic><topic>Brain damage</topic><topic>Chemistry</topic><topic>Ligands</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Ruthenium compounds</topic><topic>Size distribution</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bataglioli, Janaina C.</creatorcontrib><creatorcontrib>Gomes, Luiza M. F.</creatorcontrib><creatorcontrib>Maunoir, Camille</creatorcontrib><creatorcontrib>Smith, Jason R.</creatorcontrib><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>McCain, Julia</creatorcontrib><creatorcontrib>Sainuddin, Tariq</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><creatorcontrib>Storr, Tim</creatorcontrib><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chemical science (Cambridge)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bataglioli, Janaina C.</au><au>Gomes, Luiza M. F.</au><au>Maunoir, Camille</au><au>Smith, Jason R.</au><au>Cole, Houston D.</au><au>McCain, Julia</au><au>Sainuddin, Tariq</au><au>Cameron, Colin G.</au><au>McFarland, Sherri A.</au><au>Storr, Tim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes</atitle><jtitle>Chemical science (Cambridge)</jtitle><date>2021-04-24</date><risdate>2021</risdate><volume>12</volume><issue>21</issue><spage>7510</spage><epage>7520</epage><pages>7510-7520</pages><issn>2041-6520</issn><eissn>2041-6539</eissn><abstract>Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive and irreversible damage to the brain. One of the hallmarks of the disease is the presence of both soluble and insoluble aggregates of the amyloid beta (Aβ) peptide in the brain, and these aggregates are considered central to disease progression. Thus, the development of small molecules capable of modulating Aβ peptide aggregation may provide critical insight into the pathophysiology of AD. In this work we investigate how photoactivation of three distorted Ru( ii ) polypyridyl complexes ( Ru1–3 ) alters the aggregation profile of the Aβ peptide. Photoactivation of Ru1–3 results in the loss of a 6,6′-dimethyl-2,2′-bipyridyl (6,6′-dmb) ligand, affording cis -exchangeable coordination sites for binding to the Aβ peptide. Both Ru1 and Ru2 contain an extended planar imidazo[4,5- f ][1,10]phenanthroline ligand, as compared to a 2,2′-bipyridine ligand for Ru3 , and we show that the presence of the phenanthroline ligand promotes covalent binding to Aβ peptide His residues, and in addition, leads to a pronounced effect on peptide aggregation immediately after photoactivation. Interestingly, all three complexes resulted in a similar aggregate size distribution at 24 h, forming insoluble amorphous aggregates as compared to significant fibril formation for peptide alone. Photoactivation of Ru1–3 in the presence of pre-formed Aβ 1–42 fibrils results in a change to amorphous aggregate morphology, with Ru1 and Ru2 forming large amorphous aggregates immediately after activation. Our results show that photoactivation of Ru1–3 in the presence of either monomeric or fibrillar Aβ 1–42 results in the formation of large amorphous aggregates as a common endpoint, with Ru complexes incorporating the extended phenanthroline ligand accelerating this process and thereby limiting the formation of oligomeric species in the initial stages of the aggregation process that are reported to show considerable toxicity.</abstract><cop>Cambridge</cop><pub>Royal Society of Chemistry</pub><pmid>34163842</pmid><doi>10.1039/D1SC00004G</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7380-2192</orcidid><orcidid>https://orcid.org/0000-0002-3163-6218</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0003-3368-2063</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-6520
ispartof Chemical science (Cambridge), 2021-04, Vol.12 (21), p.7510-7520
issn 2041-6520
2041-6539
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8171320
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
subjects Agglomeration
Aggregates
Alzheimer's disease
Binding
Brain damage
Chemistry
Ligands
Morphology
Peptides
Ruthenium compounds
Size distribution
Toxicity
title Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru( ii ) polypyridyl complexes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A03%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modification%20of%20amyloid-beta%20peptide%20aggregation%20via%20photoactivation%20of%20strained%20Ru(%20ii%20)%20polypyridyl%20complexes&rft.jtitle=Chemical%20science%20(Cambridge)&rft.au=Bataglioli,%20Janaina%20C.&rft.date=2021-04-24&rft.volume=12&rft.issue=21&rft.spage=7510&rft.epage=7520&rft.pages=7510-7520&rft.issn=2041-6520&rft.eissn=2041-6539&rft_id=info:doi/10.1039/D1SC00004G&rft_dat=%3Cproquest_pubme%3E2535830547%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2535830547&rft_id=info:pmid/34163842&rfr_iscdi=true